Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

At this time, I suspect your doctor will order some radiology tests, possibly a bone scan to look for the distant spread of ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Then on April 28, it elevated to 29.3 ng/mL, at which time my oncologist prescribed an ... DEAR DR. ROACH: I have three ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially ...

I am sorry, but it is very likely that the cancer has come back somewhere in your body. However, this is not 100 per cent ...

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Consumers are becoming more concerned about their health, with many prioritising weight loss. But what do they consider to be ...